{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:59:05Z","timestamp":1781344745261,"version":"3.54.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00428-025-04242-y","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T09:28:53Z","timestamp":1760347733000},"page":"1365-1377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discovery metabolomics and genetic analysis reveal\u00a0lipid pathway alterations associated with malignant phenotype acquisition in pleomorphic adenoma and a novel NTF3::ITPR2 fusion in carcinoma ex pleomorphic adenoma"],"prefix":"10.1007","volume":"488","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5045-6960","authenticated-orcid":false,"given":"Reydson Alcides","family":"de Lima-Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"de Carvalho Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Figueira","family":"Scarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luccas","family":"Lavareze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayn\u00e1 Figueiredo","family":"Maciel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Iara","family":"Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Wachter","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"de Sousa Mesquita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Val\u00e9ria Colnaghi","family":"Simionato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Mart\u00ednek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Michal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Paulo","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Said Abu","family":"Egal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albina","family":"Altemani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Sk\u00e1lov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda Viviane","family":"Mariano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"4242_CR1","volume-title":"Head and neck tumours, WHO classification of tumours","author":"WHO Classification of Tumours Editorial Board","year":"2022","unstructured":"WHO Classification of Tumours Editorial Board (2022) Head and neck tumours, WHO classification of tumours, 5th edn. International Agency for Research on Cancer, Lyon. https:\/\/publications.iarc.fr\/","edition":"5"},{"key":"4242_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1177\/1066896919854181","volume":"27","author":"ME P\u00e9rez-de-Oliveira","year":"2019","unstructured":"P\u00e9rez-de-Oliveira ME, da Silva Leonel ACL, de Castro JFL et al (2019) Histopathological findings of intraoral pleomorphic adenomas: a retrospective study of a case series. Int J Surg Pathol 27:729\u2013735. https:\/\/doi.org\/10.1177\/1066896919854181","journal-title":"Int J Surg Pathol"},{"key":"4242_CR3","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1002\/lary.24964","volume":"125","author":"RL Witt","year":"2015","unstructured":"Witt RL, Eisele DW, Morton RP et al (2015) Etiology and management of recurrent parotid pleomorphic adenoma. Laryngoscope 125:888\u2013893. https:\/\/doi.org\/10.1002\/lary.24964","journal-title":"Laryngoscope"},{"issue":"Suppl 1","key":"4242_CR4","doi-asserted-by":"publisher","first-page":"E1364","DOI":"10.1002\/hed.24228","volume":"38","author":"S Andreasen","year":"2016","unstructured":"Andreasen S, Therkildsen MH, Bj\u00f8rndal K, Hom\u00f8e P (2016) Pleomorphic adenoma of the parotid gland 1985\u20132010: a Danish nationwide study of incidence, recurrence rate, and malignant transformation. Head Neck 38(Suppl 1):E1364\u2013E1369. https:\/\/doi.org\/10.1002\/hed.24228","journal-title":"Head Neck"},{"issue":"6","key":"4242_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2559.2005.02157.x","volume":"46","author":"A Altemani","year":"2005","unstructured":"Altemani A, Martins MT, Freitas L et al (2005) Carcinoma ex pleomorphic adenoma (CXPA): immunoprofile of the cells involved in carcinomatous progression. Histopathology 46(6):635\u2013641. https:\/\/doi.org\/10.1111\/j.1365-2559.2005.02157.x","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"4242_CR6","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1007\/s12105-013-0454-z","volume":"7","author":"S Di Palma","year":"2013","unstructured":"Di Palma S (2013) Carcinoma ex pleomorphic adenoma, with particular emphasis on early lesions. Head Neck Pathol 7(Suppl 1):S68\u2013S76. https:\/\/doi.org\/10.1007\/s12105-013-0454-z","journal-title":"Head Neck Pathol"},{"key":"4242_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ijom.2013.02.012","volume":"42","author":"FV Mariano","year":"2013","unstructured":"Mariano FV, Noronha ALF, Gondak RO et al (2013) Carcinoma ex pleomorphic adenoma in a Brazilian population: clinico-pathological analysis of 38 cases. Int J Oral Maxillofac Surg 42:685\u2013692. https:\/\/doi.org\/10.1016\/j.ijom.2013.02.012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4242_CR8","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/odi.14102","volume":"29","author":"RA de Lima-Souza","year":"2023","unstructured":"de Lima-Souza RA, Scarini JF, Lavareze L et al (2023) Discovery proteomics reveals potential protein signature associated with malignant phenotype acquisition in pleomorphic adenoma. Oral Dis 29:1017\u20131027. https:\/\/doi.org\/10.1111\/odi.14102","journal-title":"Oral Dis"},{"key":"4242_CR9","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1111\/odi.13332","volume":"26","author":"JF Scarini","year":"2020","unstructured":"Scarini JF, Rosa LF, de Lima-Souza RA et al (2020) Gene and immunohistochemical expression of HIF-1\u03b1, GLUT-1, FASN, and adipophilin in carcinoma ex pleomorphic adenoma development. Oral Dis 26:1190\u20131199. https:\/\/doi.org\/10.1111\/odi.13332","journal-title":"Oral Dis"},{"key":"4242_CR10","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hed.27717","volume":"46","author":"TdeC Kimura","year":"2024","unstructured":"Kimura TdeC, Scarini JF, Lavareze L et al (2024) Microrna copy number alterations in the malignant transformation of pleomorphic adenoma to carcinoma ex pleomorphic adenoma. Head Neck 46:985\u20131000. https:\/\/doi.org\/10.1002\/hed.27717","journal-title":"Head Neck"},{"key":"4242_CR11","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1007\/s10792-021-02096-2","volume":"42","author":"RA de Lima-Souza","year":"2022","unstructured":"de Lima-Souza RA, de Magalh\u00e3es Rodrigues N, Scarini JF et al (2022) Metabolic alterations in carcinoma ex pleomorphic adenoma development of lacrimal glands. Int Ophthalmol 42:1101\u20131109. https:\/\/doi.org\/10.1007\/s10792-021-02096-2","journal-title":"Int Ophthalmol"},{"key":"4242_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.humpath.2014.08.017","volume":"46","author":"N Katabi","year":"2015","unstructured":"Katabi N, Ghossein R, Ho A et al (2015) Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts. Hum Pathol 46:26\u201333. https:\/\/doi.org\/10.1016\/j.humpath.2014.08.017","journal-title":"Hum Pathol"},{"key":"4242_CR13","doi-asserted-by":"publisher","DOI":"10.1111\/odi.15109","author":"VG Zanella","year":"2024","unstructured":"Zanella VG, Costa SFDS, Schuch LF et al (2024) Pleomorphic adenoma and carcinoma ex-pleomorphic adenoma tumorigenesis: a proteomic analysis. Oral Dis. https:\/\/doi.org\/10.1111\/odi.15109","journal-title":"Oral Dis"},{"key":"4242_CR14","doi-asserted-by":"publisher","first-page":"104494","DOI":"10.1016\/j.critrevonc.2024.104494","volume":"204","author":"RA de Lima-Souza","year":"2024","unstructured":"de Lima-Souza RA, de Souza Vieira G, de Carvalho Kimura T et al (2024) Insights into the molecular alterations of PLAG1 and HMGA2 associated with malignant phenotype acquisition in pleomorphic adenoma. Crit Rev Oncol Hematol 204:104494. https:\/\/doi.org\/10.1016\/j.critrevonc.2024.104494","journal-title":"Crit Rev Oncol Hematol"},{"key":"4242_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/0471142727.mb3004s114","volume":"114","author":"O Fiehn","year":"2016","unstructured":"Fiehn O (2016) Metabolomics by gas chromatography-mass spectrometry: combined targeted and untargeted profiling. Curr Protoc Mol Biol 114:30.4.1-30.4.32. https:\/\/doi.org\/10.1002\/0471142727.mb3004s114","journal-title":"Curr Protoc Mol Biol"},{"key":"4242_CR16","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1007\/s00216-020-02881-5","volume":"412","author":"GH Bueno Duarte","year":"2020","unstructured":"Bueno Duarte GH, de Piloto Fernandes AMA, Silva AAR et al (2020) Gas chromatography-mass spectrometry untargeted profiling of non-Hodgkin\u2019s lymphoma urinary metabolite markers. Anal Bioanal Chem 412:7469\u20137480. https:\/\/doi.org\/10.1007\/s00216-020-02881-5","journal-title":"Anal Bioanal Chem"},{"key":"4242_CR17","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1080\/10428194.2023.2234523","volume":"64","author":"CI Rodrigues-Fernandes","year":"2023","unstructured":"Rodrigues-Fernandes CI, Martins-Chaves RR, Vit\u00f3rio JG et al (2023) The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified. Leuk Lymphoma 64:1771\u20131781. https:\/\/doi.org\/10.1080\/10428194.2023.2234523","journal-title":"Leuk Lymphoma"},{"key":"4242_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.clinbiochem.2012.05.012","volume":"45","author":"L Zhang","year":"2012","unstructured":"Zhang L, Jin H, Guo X et al (2012) Distinguishing pancreatic cancer from chronic pancreatitis and healthy individuals by 1H nuclear magnetic resonance-based metabonomic profiles. Clin Biochem 45:1064\u20131069. https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.05.012","journal-title":"Clin Biochem"},{"key":"4242_CR19","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1104\/pp.111.173609","volume":"155","author":"AE Ricroch","year":"2011","unstructured":"Ricroch AE, Berg\u00e9 JB, Kuntz M (2011) Evaluation of genetically engineered crops using transcriptomic, proteomic, and metabolomic profiling techniques. Plant Physiol 155:1752\u20131761. https:\/\/doi.org\/10.1104\/pp.111.173609","journal-title":"Plant Physiol"},{"key":"4242_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136902","volume":"10","author":"A Wojakowska","year":"2015","unstructured":"Wojakowska A, Marczak \u0141, Jelonek K et al (2015) An optimized method of metabolite extraction from formalin-fixed paraffin-embedded tissue for GC\/MS analysis. PLoS ONE 10:e0136902. https:\/\/doi.org\/10.1371\/journal.pone.0136902","journal-title":"PLoS ONE"},{"key":"4242_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nmeth.3393","volume":"12","author":"H Tsugawa","year":"2015","unstructured":"Tsugawa H, Cajka T, Kind T et al (2015) MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat Methods 12:523\u2013526. https:\/\/doi.org\/10.1038\/nmeth.3393","journal-title":"Nat Methods"},{"key":"4242_CR22","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner LW, Amberg A, Barrett D et al (2007) Proposed minimum reporting standards for chemical analysis chemical analysis working group (CAWG) metabolomics standards initiative (MSI). Metabolomics 3:211\u2013221. https:\/\/doi.org\/10.1007\/s11306-007-0082-2","journal-title":"Metabolomics"},{"key":"4242_CR23","doi-asserted-by":"publisher","first-page":"D622","DOI":"10.1093\/nar\/gkab1062","volume":"50","author":"DS Wishart","year":"2022","unstructured":"Wishart DS, Guo A, Oler E et al (2022) HMDB 5.0: the human metabolome database for 2022. Nucleic Acids Res 50:D622\u2013D631. https:\/\/doi.org\/10.1093\/nar\/gkab1062","journal-title":"Nucleic Acids Res"},{"key":"4242_CR24","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang Z, Lu Y, Zhou G et al (2024) Metaboanalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res 52:W398\u2013W406. https:\/\/doi.org\/10.1093\/nar\/gkae253","journal-title":"Nucleic Acids Res"},{"key":"4242_CR25","doi-asserted-by":"publisher","first-page":"D1062","DOI":"10.1093\/nar\/gkx1153","volume":"46","author":"MJ Landrum","year":"2018","unstructured":"Landrum MJ, Lee JM, Benson M et al (2018) Clinvar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res 46:D1062\u2013D1067. https:\/\/doi.org\/10.1093\/nar\/gkx1153","journal-title":"Nucleic Acids Res"},{"key":"4242_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13073-020-00791-w","volume":"12","author":"DC Koboldt","year":"2020","unstructured":"Koboldt DC (2020) Best practices for variant calling in clinical sequencing. Genome Med 12:91. https:\/\/doi.org\/10.1186\/s13073-020-00791-w","journal-title":"Genome Med"},{"key":"4242_CR27","doi-asserted-by":"publisher","first-page":"237","DOI":"10.15430\/JCP.2021.26.4.237","volume":"26","author":"MK Jung","year":"2021","unstructured":"Jung MK, Okekunle AP, Lee JE et al (2021) Role of branched-chain amino acid metabolism in tumor development and progression. J Cancer Prev 26:237\u2013243. https:\/\/doi.org\/10.15430\/JCP.2021.26.4.237","journal-title":"J Cancer Prev"},{"key":"4242_CR28","doi-asserted-by":"publisher","first-page":"3367","DOI":"10.1242\/jcs.181016","volume":"129","author":"A Vazquez","year":"2016","unstructured":"Vazquez A, Kamphorst JJ, Markert EK et al (2016) Cancer metabolism at a glance. J Cell Sci 129:3367\u20133373. https:\/\/doi.org\/10.1242\/jcs.181016","journal-title":"J Cell Sci"},{"key":"4242_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2:e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Sci Adv"},{"key":"4242_CR30","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/MCO.0000000000000430","volume":"21","author":"EA Ananieva","year":"2018","unstructured":"Ananieva EA, Wilkinson AC (2018) Branched-chain amino acid metabolism in cancer. Curr Opin Clin Nutr Metab Care 21:64\u201370. https:\/\/doi.org\/10.1097\/MCO.0000000000000430","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4242_CR31","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/his.12778","volume":"68","author":"I-W Chang","year":"2016","unstructured":"Chang I-W, Wu W, Wang Y-H et al (2016) BCAT1 overexpression is an indicator of poor prognosis in patients with urothelial carcinomas of the upper urinary tract and urinary bladder. Histopathology 68:520\u2013532. https:\/\/doi.org\/10.1111\/his.12778","journal-title":"Histopathology"},{"issue":"12","key":"4242_CR32","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1111\/liv.13178","volume":"36","author":"Y-H Zheng","year":"2016","unstructured":"Zheng Y-H, Hu W-J, Chen B-C et al (2016) <scp>BCAT<\/scp>1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin. Liver Int 36(12):1836\u20131847. https:\/\/doi.org\/10.1111\/liv.13178","journal-title":"Liver Int"},{"key":"4242_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.humpath.2018.02.003","volume":"75","author":"Y Xu","year":"2018","unstructured":"Xu Y, Yu W, Yang T et al (2018) Overexpression of BCAT1 is a prognostic marker in gastric cancer. Hum Pathol 75:41\u201346. https:\/\/doi.org\/10.1016\/j.humpath.2018.02.003","journal-title":"Hum Pathol"},{"key":"4242_CR34","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.bbcan.2014.10.007","volume":"1846","author":"K Xu","year":"2014","unstructured":"Xu K, Liu P, Wei W (2014) mTOR signaling in tumorigenesis. Biochim Biophys Acta Rev Cancer 1846:638\u2013654. https:\/\/doi.org\/10.1016\/j.bbcan.2014.10.007","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4242_CR35","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1079\/PNS2004355","volume":"63","author":"DR Bolster","year":"2004","unstructured":"Bolster DR, Jefferson LS, Kimball SR (2004) Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin-, amino acid- and exercise-induced signalling. Proc Nutr Soc 63:351\u2013356. https:\/\/doi.org\/10.1079\/PNS2004355","journal-title":"Proc Nutr Soc"},{"key":"4242_CR36","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-15-2568","volume":"22","author":"K Wang","year":"2016","unstructured":"Wang K, Russell JS, McDermott JD et al (2016) Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations. Clin Cancer Res 22:6061\u20136068. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2568","journal-title":"Clin Cancer Res"},{"key":"4242_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000002307","author":"RA de Lima-Souza","year":"2024","unstructured":"de Lima-Souza RA, Altemani A, Michal M et al (2024) Expanding the molecular spectrum of carcinoma ex pleomorphic adenoma. Am J Surg Pathol. https:\/\/doi.org\/10.1097\/PAS.0000000000002307","journal-title":"Am J Surg Pathol"},{"key":"4242_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000021207","volume":"99","author":"Y Iida","year":"2020","unstructured":"Iida Y, Serizawa M, Mukaigawa T et al (2020) Molecular profile of a pleomorphic adenoma of the hard palate. Medicine (Baltimore) 99:e21207. https:\/\/doi.org\/10.1097\/MD.0000000000021207","journal-title":"Medicine (Baltimore)"},{"key":"4242_CR39","doi-asserted-by":"publisher","first-page":"1220638","DOI":"10.3389\/fonc.2023.1220638","volume":"13","author":"E Xu","year":"2023","unstructured":"Xu E, Ji B, Jin K, Chen Y (2023) Branched-chain amino acids catabolism and cancer progression: focus on therapeutic interventions. Front Oncol 13:1220638. https:\/\/doi.org\/10.3389\/fonc.2023.1220638","journal-title":"Front Oncol"},{"key":"4242_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.932670","volume":"9","author":"C Du","year":"2022","unstructured":"Du C, Liu W-J, Yang J et al (2022) The role of branched-chain amino acids and branched-chain \u03b1-keto acid dehydrogenase kinase in metabolic disorders. Front Nutr 9:932670. https:\/\/doi.org\/10.3389\/fnut.2022.932670","journal-title":"Front Nutr"},{"key":"4242_CR41","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40170-024-00335-5","volume":"12","author":"K Gotvaldov\u00e1","year":"2024","unstructured":"Gotvaldov\u00e1 K, \u0160pa\u010dkov\u00e1 J, Novotn\u00fd J et al (2024) BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria. Cancer Metab 12:10. https:\/\/doi.org\/10.1186\/s40170-024-00335-5","journal-title":"Cancer Metab"},{"key":"4242_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00013","volume":"8","author":"ACB Sant\u2019Anna-Silva","year":"2018","unstructured":"Sant\u2019Anna-Silva ACB, Santos GC, Campos SPC et al (2018) Metabolic profile of oral squamous carcinoma cell lines relies on a higher demand of lipid metabolism in metastatic cells. Front Oncol 8:13. https:\/\/doi.org\/10.3389\/fonc.2018.00013","journal-title":"Front Oncol"},{"key":"4242_CR43","doi-asserted-by":"publisher","first-page":"23645","DOI":"10.1038\/s41598-024-63763-9","volume":"14","author":"JF Scarini","year":"2024","unstructured":"Scarini JF, Sabino WL, de Lima-Souza RA et al (2024) Distinct copy number signatures between residual benign and transformed areas of carcinoma ex pleomorphic adenoma. Sci Rep 14:23645. https:\/\/doi.org\/10.1038\/s41598-024-63763-9","journal-title":"Sci Rep"},{"key":"4242_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1111\/jop.12820","volume":"48","author":"KP D\u00edaz","year":"2019","unstructured":"D\u00edaz KP, Gondak R, Martins LL et al (2019) Fatty acid synthase and Ki-67 immunoexpression can be useful for the identification of malignant component in carcinoma ex-pleomorphic adenoma. J Oral Pathol Med 48:232\u2013238. https:\/\/doi.org\/10.1111\/jop.12820","journal-title":"J Oral Pathol Med"},{"key":"4242_CR45","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s12105-021-01319-3","volume":"15","author":"CM de Angelis","year":"2021","unstructured":"de Angelis CM, de Lima-Souza RA, Scarini JF et al (2021) Immunohistochemical expression of Fatty Acid Synthase (FASN) is correlated to tumor aggressiveness and cellular differentiation in salivary gland carcinomas. Head Neck Pathol 15:1119\u20131126. https:\/\/doi.org\/10.1007\/s12105-021-01319-3","journal-title":"Head Neck Pathol"},{"key":"4242_CR46","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1093\/abbs\/gms112","volume":"45","author":"X Xiao","year":"2013","unstructured":"Xiao X, Song B-L (2013) SREBP: a novel therapeutic target. Acta Biochim Biophys Sin (Shanghai) 45:2\u201310. https:\/\/doi.org\/10.1093\/abbs\/gms112","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"4242_CR47","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1210\/mend.14.5.0459","volume":"14","author":"KA Tobin","year":"2000","unstructured":"Tobin KA, Steineger HH, Alberti S et al (2000) Cross-talk between fatty acid and cholesterol metabolism mediated by liver X receptor-alpha. Mol Endocrinol 14:741\u2013752. https:\/\/doi.org\/10.1210\/mend.14.5.0459","journal-title":"Mol Endocrinol"},{"key":"4242_CR48","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.cell.2017.07.029","volume":"170","author":"DA Fruman","year":"2017","unstructured":"Fruman DA, Chiu H, Hopkins BD et al (2017) The PI3K pathway in human disease. Cell 170:605\u2013635. https:\/\/doi.org\/10.1016\/j.cell.2017.07.029","journal-title":"Cell"},{"key":"4242_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","volume":"45","author":"EC Lien","year":"2017","unstructured":"Lien EC, Dibble CC, Toker A (2017) PI3K signaling in cancer: beyond AKT. Curr Opin Cell Biol 45:62\u201371. https:\/\/doi.org\/10.1016\/j.ceb.2017.02.007","journal-title":"Curr Opin Cell Biol"},{"key":"4242_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbior.2013.11.001","volume":"54","author":"Q Zhang","year":"2014","unstructured":"Zhang Q, Wakelam MJO (2014) Lipidomics in the analysis of malignancy. Adv Biol Regul 54:93\u201398. https:\/\/doi.org\/10.1016\/j.jbior.2013.11.001","journal-title":"Adv Biol Regul"},{"key":"4242_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1039\/C9MO00128J","volume":"16","author":"J Molendijk","year":"2020","unstructured":"Molendijk J, Robinson H, Djuric Z, Hill MM (2020) Lipid mechanisms in hallmarks of cancer. Mol Omics 16:6\u201318. https:\/\/doi.org\/10.1039\/C9MO00128J","journal-title":"Mol Omics"},{"key":"4242_CR52","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jop.12839","volume":"48","author":"FF Duarte-Andrade","year":"2019","unstructured":"Duarte-Andrade FF, Silva AMB, Vit\u00f3rio JG et al (2019) The importance of BRAF-V600E mutation to ameloblastoma metabolism. J Oral Pathol Med 48:307\u2013314. https:\/\/doi.org\/10.1111\/jop.12839","journal-title":"J Oral Pathol Med"},{"key":"4242_CR53","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-020-01727-6","volume":"16","author":"JG Vit\u00f3rio","year":"2020","unstructured":"Vit\u00f3rio JG, Duarte-Andrade FF, Dos Santos Fontes Pereira T et al (2020) Metabolic landscape of oral squamous cell carcinoma. Metabolomics 16:105. https:\/\/doi.org\/10.1007\/s11306-020-01727-6","journal-title":"Metabolomics"},{"key":"4242_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12010-011-9240-0","volume":"165","author":"D OuYang","year":"2011","unstructured":"OuYang D, Xu J, Huang H, Chen Z (2011) Metabolomic profiling of serum from human pancreatic cancer patients using 1H NMR spectroscopy and principal component analysis. Appl Biochem Biotechnol 165:148\u2013154. https:\/\/doi.org\/10.1007\/s12010-011-9240-0","journal-title":"Appl Biochem Biotechnol"},{"key":"4242_CR55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.humpath.2019.08.009","volume":"93","author":"T Santana","year":"2019","unstructured":"Santana T, Pavel A, Martinek P et al (2019) Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications. Hum Pathol 93:37\u201347. https:\/\/doi.org\/10.1016\/j.humpath.2019.08.009","journal-title":"Hum Pathol"},{"key":"4242_CR56","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1158\/1078-0432.CCR-16-0637","volume":"22","author":"MG Dalin","year":"2016","unstructured":"Dalin MG, Desrichard A, Katabi N et al (2016) Comprehensive molecular characterization of salivary duct carcinoma reveals actionable targets and similarity to apocrine breast cancer. Clin Cancer Res 22:4623\u20134633. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-0637","journal-title":"Clin Cancer Res"},{"key":"4242_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.011","volume":"57","author":"BS de Brito","year":"2016","unstructured":"de Brito BS, Giovanelli N, Egal ES et al (2016) Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma. Hum Pathol 57:152\u2013159. https:\/\/doi.org\/10.1016\/j.humpath.2016.07.011","journal-title":"Hum Pathol"},{"key":"4242_CR58","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/his.13246","volume":"71","author":"JK Mito","year":"2017","unstructured":"Mito JK, Jo VY, Chiosea SI et al (2017) HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Histopathology 71:511\u2013521. https:\/\/doi.org\/10.1111\/his.13246","journal-title":"Histopathology"},{"key":"4242_CR59","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s12105-018-0984-5","volume":"13","author":"L Liang","year":"2019","unstructured":"Liang L, Williams MD, Bell D (2019) Expression of PTEN, androgen receptor, HER2\/neu, cytokeratin 5\/6, estrogen receptor-beta, HMGA2, and PLAG1 in salivary duct carcinoma. Head Neck Pathol 13:529\u2013534. https:\/\/doi.org\/10.1007\/s12105-018-0984-5","journal-title":"Head Neck Pathol"},{"key":"4242_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.795849","volume":"8","author":"R Liu","year":"2021","unstructured":"Liu R, Li R, Yu H et al (2021) NTF3 correlates with prognosis and immune infiltration in hepatocellular carcinoma. Front Med 8:795849. https:\/\/doi.org\/10.3389\/fmed.2021.795849","journal-title":"Front Med"},{"key":"4242_CR61","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.7150\/ijbs.72982","volume":"18","author":"Z Yang","year":"2022","unstructured":"Yang Z, Zhang H, Yin M et al (2022) Neurotrophin3 promotes hepatocellular carcinoma apoptosis through the JNK and P38 MAPK pathways. Int J Biol Sci 18:5963\u20135977. https:\/\/doi.org\/10.7150\/ijbs.72982","journal-title":"Int J Biol Sci"},{"key":"4242_CR62","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.bbamcr.2014.12.006","volume":"1853","author":"T Vervloessem","year":"2015","unstructured":"Vervloessem T, Yule DI, Bultynck G, Parys JB (2015) The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca2+-release channel. Biochim Biophys Acta 1853:1992\u20132005. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.12.006","journal-title":"Biochim Biophys Acta"},{"key":"4242_CR63","doi-asserted-by":"publisher","first-page":"5299","DOI":"10.18632\/oncotarget.3024","volume":"6","author":"J Shi","year":"2015","unstructured":"Shi J, Fu L, Wang W (2015) High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia. Oncotarget 6:5299\u20135309. https:\/\/doi.org\/10.18632\/oncotarget.3024","journal-title":"Oncotarget"},{"key":"4242_CR64","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/gcc.22979","volume":"60","author":"J Bubola","year":"2021","unstructured":"Bubola J, MacMillan CM, Demicco EG et al (2021) Targeted <scp>RNA<\/scp> sequencing in the routine clinical detection of fusion genes in salivary gland tumors. Genes Chromosomes Cancer 60:695\u2013708. https:\/\/doi.org\/10.1002\/gcc.22979","journal-title":"Genes Chromosomes Cancer"},{"key":"4242_CR65","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.70023","volume":"64","author":"MK Afshari","year":"2025","unstructured":"Afshari MK, Tejera Nevado P, Fehr A et al (2025) The transcriptomic and gene fusion landscape of pleomorphic salivary gland adenomas. Genes Chromosomes Cancer 64:e70023. https:\/\/doi.org\/10.1002\/gcc.70023","journal-title":"Genes Chromosomes Cancer"},{"key":"4242_CR66","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.humpath.2020.07.009","volume":"103","author":"M Ban\u011b\u010dkov\u00e1","year":"2020","unstructured":"Ban\u011b\u010dkov\u00e1 M, Uro-Coste E, Pt\u00e1kov\u00e1 N et al (2020) What is hiding behind S100 protein and SOX10 positive oncocytomas? Oncocytic pleomorphic adenoma and myoepithelioma with novel gene fusions in a subset of cases. Hum Pathol 103:52\u201362. https:\/\/doi.org\/10.1016\/j.humpath.2020.07.009","journal-title":"Hum Pathol"},{"key":"4242_CR67","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"4242_CR68","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04242-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04242-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T09:54:32Z","timestamp":1781344472000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04242-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4242"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04242-y","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"26 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Rreview Board (Protocol numbers: 4.231.600 and 4.397.077).\u00a0The procedures followed in this study were conducted in accordance with the principles of the Declaration of Helsinki (2024 revision).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}